26. HTLV-1-associated myelopathy Clinical trials / Disease details


Clinical trials : 28 Drugs : 48 - (DrugBank : 28) / Drug target genes : 38 - Drug target pathways : 127

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04799288
(ClinicalTrials.gov)
September 24, 202113/3/2021Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic ParaparesisPhase I/II Study of Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic ParaparesisHAM/TSPDrug: TeriflunomideNational Institute of Neurological Disorders and Stroke (NINDS)NULLRecruiting18 YearsN/AAll16Phase 1/Phase 2United States